Menu
Back to Journals » ClinicoEconomics and Outcomes Research » Volume 12
Original Research
A Cost per Responder Model for Abatacept versus Adalimumab Among Rheumatoid Arthritis Patients with Seropositivity
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 5,152 | Dovepress* | 4,790+ | 896 | 5,686 | |
| PubMed Central* | 362 | 116 | 478 | ||
| Totals | 5,152 | 1,012 | 6,164 | ||
| *Since 15 October 2020 | |||||
View citations on PubMed and Google Scholar